The diabetes drugs glucagon-like peptide-1 (GLP-1) receptor agonists and sodium glucose cotransporter 2 (SGLT-2) inhibitor ...

With respect to cardiovascular and renal outcomes, combined therapy with SGLT2 inhibitors and GLP-1 receptor agonists has scant benefit compared with using either drug alone in patients with type 2 ...

Please provide your email address to receive an email when new articles are posted on . GLP-1 drugs were favored in those at moderate kidney failure risk while SGLT2 inhibitors were favored at high ...

The diabetes drugs glucagon-like peptide-1 (GLP-1) receptor agonists and sodium glucose cotransporter 2 (SGLT-2) inhibitor drugs may also help to slow decline in kidney function in people with ...

BUFFALO, N.Y. — Individuals with atrial fibrillation (Afib), or irregular heart rhythm, are at increased risk of stroke, chronic kidney disease and heart failure. These risks are significantly ...

CHICAGO -- Use of GLP-1 receptor agonists was tied to significantly lower risks of major diabetic foot complications compared with SGLT2 inhibitors in adults with type 2 diabetes, a large, real-world ...

Exton, PA, May 13, 2026 (GLOBE NEWSWIRE) -- Nephrologists are initiating SGLT2 inhibitors earlier in the chronic kidney disease (CKD) treatment journey and continuing them well below labeled eGFR ...

Please provide your email address to receive an email when new articles are posted on . Fewer than 10% of nephrologists prescribe glucose-lowering drugs. Nephrologists are well positioned to ...

The list of health conditions that benefit from the GLP-1 weight loss and diabetes drugs like Ozempic, Wegovy, Mounjaro and Zepbound, continues to grow. The drugs are already approved to lower the ...

Tuberculosis (TB) continues to pose a major global health challenge, with an estimated 10.8 million people developing the disease in 2023. The persistent burden of TB is compounded by the emergence of ...

Individuals with atrial fibrillation (Afib), or irregular heart rhythm, are at increased risk of stroke, chronic kidney disease and heart failure. These risks are significantly exacerbated if a type 2 ...